Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01955356Not ApplicableCompleted

Embryo Implantation After Induced Endometrial Injury

Role: collaborator

NCT02527954Terminated

Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions

Role: collaborator

NCT03436758Unknown

Validation of Addition of Uterine Fluid to Human Embryo Culture Medium

Role: lead

NCT03307655Not ApplicableUnknown

Relationship Between Nitric Oxide (NO) in Follicular Fluid and Sperm Fertilization Ability

Role: lead

All 4 trials loaded